BRIEF-Edesa Biotech Reports Positive Results In Phase 3 Respiratory Study

Reuters10-28

BRIEF-<a href="https://laohu8.com/S/EDSA">Edesa Biotech</a> Reports Positive Results In Phase 3 Respiratory Study

Edesa Biotech Inc EDSA.O:

EDESA BIOTECH REPORTS POSITIVE RESULTS IN PHASE 3 RESPIRATORY STUDY
EDESA BIOTECH INC: STUDY MET PRIMARY AND SECONDARY ENDPOINTS
EDESA BIOTECH INC - PARIDIPRUBART SHOWS 25% REDUCTION IN RISK OF DEATH
EDESA BIOTECH INC - EB05 WELL-TOLERATED IN SAFETY POPULATION OF OVER 275 SUBJECTS
EDESA BIOTECH INC - PARIDIPRUBART PLUS SOC SHOWS 13% IMPROVEMENT IN SURVIVAL

Source text: ID:nGNX1FjRDp

Further company coverage: EDSA.O

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2578959249?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-28 20:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2578959249","market":"us","top_or_hot":-1,"title":"BRIEF-Edesa Biotech Reports Positive Results In Phase 3 Respiratory Study","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-<a href=\"https://laohu8.com/S/EDSA\">Edesa Biotech</a> Reports Positive Results In Phase 3 Respiratory Study</title></head><body><p>Edesa Biotech Inc <span>EDSA.O</span>:</p><ul><li><p>EDESA BIOTECH REPORTS POSITIVE RESULTS IN PHASE 3 RESPIRATORY STUDY</p></li><li><p>EDESA BIOTECH INC: STUDY MET PRIMARY AND SECONDARY ENDPOINTS</p></li><li><p>EDESA BIOTECH INC - PARIDIPRUBART SHOWS 25% REDUCTION IN RISK OF DEATH</p></li><li><p>EDESA BIOTECH INC - EB05 WELL-TOLERATED IN SAFETY POPULATION OF OVER 275 SUBJECTS</p></li><li><p>EDESA BIOTECH INC - PARIDIPRUBART PLUS SOC SHOWS 13% IMPROVEMENT IN SURVIVAL</p></li></ul><p>Source text: <span>ID:nGNX1FjRDp</span></p><p>Further company coverage: <span>EDSA.O</span></p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Edesa Biotech Reports Positive Results In Phase 3 Respiratory Study</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Edesa Biotech Reports Positive Results In Phase 3 Respiratory Study\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-10-28 20:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-<a href=\"https://laohu8.com/S/EDSA\">Edesa Biotech</a> Reports Positive Results In Phase 3 Respiratory Study</title></head><body><p>Edesa Biotech Inc <span>EDSA.O</span>:</p><ul><li><p>EDESA BIOTECH REPORTS POSITIVE RESULTS IN PHASE 3 RESPIRATORY STUDY</p></li><li><p>EDESA BIOTECH INC: STUDY MET PRIMARY AND SECONDARY ENDPOINTS</p></li><li><p>EDESA BIOTECH INC - PARIDIPRUBART SHOWS 25% REDUCTION IN RISK OF DEATH</p></li><li><p>EDESA BIOTECH INC - EB05 WELL-TOLERATED IN SAFETY POPULATION OF OVER 275 SUBJECTS</p></li><li><p>EDESA BIOTECH INC - PARIDIPRUBART PLUS SOC SHOWS 13% IMPROVEMENT IN SURVIVAL</p></li></ul><p>Source text: <span>ID:nGNX1FjRDp</span></p><p>Further company coverage: <span>EDSA.O</span></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251028:nFWN3W90GM:1","article_id":"2578959249","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2578959249","pubTimestamp":1761653440,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Edesa Biotech Reports Positive Results In Phase 3 Respiratory StudyEdesa Biotech Inc EDSA.O:EDESA BIOTECH REPORTS POSITIVE RESULTS IN PHASE 3 RESPIRATORY STUDYEDESA BIOTECH INC: STUDY MET PRIMAR","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","EDSA":"Edesa Biotech"},"translate_title":"简介-Edesa Biotech报告3期呼吸研究的积极结果","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"EDSA":0.9},"content_text":"BRIEF-Edesa Biotech Reports Positive Results In Phase 3 Respiratory StudyEdesa Biotech Inc EDSA.O:EDESA BIOTECH REPORTS POSITIVE RESULTS IN PHASE 3 RESPIRATORY STUDYEDESA BIOTECH INC: STUDY MET PRIMARY AND SECONDARY ENDPOINTSEDESA BIOTECH INC - PARIDIPRUBART SHOWS 25% REDUCTION IN RISK OF DEATHEDESA BIOTECH INC - EB05 WELL-TOLERATED IN SAFETY POPULATION OF OVER 275 SUBJECTSEDESA BIOTECH INC - PARIDIPRUBART PLUS SOC SHOWS 13% IMPROVEMENT IN SURVIVALSource text: ID:nGNX1FjRDpFurther company coverage: EDSA.O","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport,express","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2578959249","isCrawlerRequest":true}